Report: Rare remission for advanced leukemia raises prospect of a cure

The University of Pennsylvania's Carl June was in the spotlight at ASH over the weekend. The New York Times featured the amazing case of Emma Whitehead, who initially almost died after June reengineered her immune system to target the leukemia which afflicted her. Seven months later she's in complete remission and June says the dramatic results--seen in a handful of patients in his tiny study--raises the prospect of a cure. Story

Suggested Articles

Fifteen of the 22 patients in a gene therapy trial no longer needed transfusions, while the remainder needed fewer transfusions.

Argos Therapeutics is ending its kidney cancer trial and mulling options, including a merger or sale, to stay alive.

CNS Pharma says berubicin is the first anthracycline drug to cross the blood-brain barrier and could transform treatment of the highly invasive brain tumor.